Uncategorized
FDA Awards Isarna Orphan Drug Designation for ISTH0036 to Improve Glaucoma Treatment Outcome
MUNICH--(BUSINESS WIRE)--Isarna Therapeutics adds FDA orphan drug designation to its ISTH0036 program to treat prevention of scarring post glaucoma filtration surgery.
